Average Co-Inventor Count = 2.45
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biosphere Medical, Inc. (14 from 30 patents)
2. Genzyme Corporation (2 from 788 patents)
3. Pluromed, Inc. (2 from 5 patents)
4. The General Hospital Corporation (1 from 2,893 patents)
5. Biospehere Medical, Inc. (1 from 1 patent)
19 patents:
1. 10265271 - Microspheres for the treatment of a prostate hyperplasia by active embolization
2. 9968369 - Non-lithotripsic kidney-stone therapy
3. 9308169 - Microspheres for active embolization
4. 9295648 - Injectable microspheres for dermal augmentation and tissue bulking
5. 9205053 - Injectable microspheres for dermal augmentation and tissue bulking
6. 9161767 - Non-lithotripsic kidney-stone therapy
7. 9017710 - Injectable and swellable microspheres for tissue bulking
8. 8932637 - Injectable and swellable microspheres for tissue bulking
9. 8778333 - Injectable microspheres for tissue construction
10. 8741351 - Microspheres for active embolization
11. 8697137 - Methods of using microspheres for active embolization
12. 8658215 - Injectable microspheres for dermal augmentation and tissue bulking
13. 8491623 - Atraumatic occlusion balloons and skirts, and methods of use thereof
14. 8361455 - Non-lithotripsic kidney-stone therapy
15. 8142815 - Injectable and swellable microspheres for dermal augmentation